Overview of FDA 505(b)(2) Regulatory Pathway

Many 505(b)(2) applications do not require the sponsor to conduct nonclinical studies. In these cases, the successful application will contain adequate evidence of safety for the proposed product.

Back

Return to all Whitepapers

Scroll to Top